Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
559
-
Total 13F shares, excl. options
-
73.3M
-
Shares change
-
-405K
-
Total reported value, excl. options
-
$34.1B
-
Value change
-
-$199M
-
Put/Call ratio
-
1.48
-
Number of buys
-
295
-
Number of sells
-
-220
-
Price
-
$465.14
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2015
638 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2015.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 559 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.3M shares
of 105M outstanding shares and own 69.77% of the company stock.
Largest 10 shareholders include Capital World Investors (6.97M shares), FMR LLC (5.61M shares), WELLINGTON MANAGEMENT GROUP LLP (5.03M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.8M shares), VANGUARD GROUP INC (4.43M shares), SANDS CAPITAL MANAGEMENT, LLC (4.14M shares), STATE STREET CORP (3.03M shares), JPMORGAN CHASE & CO (2.54M shares), BlackRock Fund Advisors (2.29M shares), and JANUS CAPITAL MANAGEMENT LLC (2.15M shares).
This table shows the top 559 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.